We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase 2 Trials Underway for New Single Dose Malaria Treatment

News   Aug 12, 2015

 
Phase 2 Trials Underway for New Single Dose Malaria Treatment
 
 
Advertisement
 

RELATED ARTICLES

Team Identifies Potential Drug Target for Severe E. coli Infections

News

UNSW Science researchers have studied an E. coli strain responsible for a severe intestinal infection in humans, enterohemorrhagic E. coli (EHEC). They have discovered a new molecular pathway that controls Shiga toxin production, this finding is important because there is no commercially available treatment for EHEC infections currently.

READ MORE

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

Redesigning Existing Antibiotics To Outmanoeuver Resistant Bacteria

News

Researchers at UC San Francisco are tackling antibiotic resistance using a different approach: redesigning existing antibiotic molecules to evade a bacterium’s resistance mechanisms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE